RecruitingNCT05296356
OSU6162 in Depression in bipolarity (OBID)
Researchers are studying OSU6162 to find out how it affects depression symptoms in people with bipolarity during a depressive episode.
Medication studyAges 18–65Sweden
Understand this study
What is this study about?
Researchers are studying OSU6162 to find out how it affects depression symptoms in people with bipolarity during a depressive episode.
Who could participate?
This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
What will I do during this study?
You take part in an open-label, eight-week study of flexible-dose OSU6162. The registry lists nine study visits and one safety visit. It is for people experiencing a depressive episode within bipolarity who are already taking at least one stable mood-stabilizing medication.
- Listed locations
- GothenburgSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Number of visits
- The registry lists 9 study visits and 1 safety visit over 8 weeks.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 25, 2021
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 22
- Sponsor
- Göteborg University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Sweden
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05296356
- Official title
Show the full official title
OSU6162 in Bipolar Depression: An Open-label, Flexible Dose Study (OBID)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Gothenburg
Interested in joining this study?
Questions about this study
What is this study about?
Researchers are studying OSU6162 to find out how it affects depression symptoms in people with bipolarity during a depressive episode.
Who is behind this study?
The study sponsor is Göteborg University, a university.
Does this study involve medication?
Yes. The study involves medication, including OSU6162.
Who can participate?
This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
